Biocon Overview
Company Headquarters: Karnataka, India
Founded: 1978
Workforce: ~16,545
Company Working: Biocon manufactures and sells generic active pharmaceutical ingredients (APIs). It also provides a variety of branded formulations, complex biologics, and biosimilars like monoclonal antibodies (MAbs), rh-Insulin, and insulin analogues in addition to several active pharmaceutical ingredients (APIs). Additionally, the company provides contract manufacturing, medicine licensing, research, development, and the production of both small and large molecules to pharmaceutical and biotechnology organizations all over the world. In order to develop solutions that meet the various needs of patients around the world, Biocon has invested in cutting-edge technology, major research collaborations, and global manufacturing scale over the years. As an emerging international company, Biocon is meeting patients' needs in more than 100 nations with unique products. It has a production unit and an R&D facility at BioXcell in Malaysia. Furthermore, it has operations in the UK, Ireland, the US, Switzerland, Dubai, and Malaysia.



